⌘K

Login Start Free

Home/Filings/4/0000950170-25-090192

4//SEC Filing

Nabel Gary J. 4

Accession 0000950170-25-090192

CIK 0001841387other

View on SEC.gov Company Profile

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 8:30 AM ET

Size

4.7 KB

Accession

0000950170-25-090192

Insider Transaction Report

Form 4

Period: 2025-06-25

Candel Therapeutics, Inc.CADL

Director

Transactions

Award
Common Stock
2025-06-25$4.67/sh+5,353$24,999→ 5,353 total

Footnotes (1)

[F1]Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Candel Therapeutics, Inc.

CIK 0001841387

Entity typeother

Related Parties

1

filerCIK 0001867450

Filing Metadata

Form type: 4
Filed: Jun 25, 8:00 PM ET
Accepted: Jun 26, 8:30 AM ET
Size: 4.7 KB

View on SEC.gov